Chitosan wound dressing with hexagonal silver nanoparticles for hyperthermia and enhanced delivery of small molecules

Colloids and Surfaces B: Biointerfaces

Volumn 142, Issue , 2016, Pages 315-324

  Levi Polyachenko, Nicole ^a   Jacob, Reuben ^a   Day, Cynthia ^b   Kuthirummal, Narayanan ^c  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

^c School of Business and Economics   (United States)

Author keywords

Chitosan; Hyperthermia; Nanoparticles; Wound dressing

Indexed keywords

CELL CULTURE; CHITIN; CHITOSAN; ELECTROMAGNETIC WAVE ABSORPTION; FILM PREPARATION; LIGHT ABSORPTION; METAL NANOPARTICLES; MOLECULES; NANOPARTICLES; SYNTHESIS (CHEMICAL); THERMOANALYSIS; X RAY DIFFRACTION;

DERMAL WOUND HEALING; DEXTRAN MOLECULES; HYPERTHERMIA; INTRACELLULAR DELIVERY; MOLECULAR CHAINS; SHAPED NANOPARTICLES; SILVER NANOPARTICLES; WOUND DRESSINGS;

SILVER;

CHITOSAN; DEXTRAN; SILVER NANOPARTICLE; FLUORESCEIN ISOTHIOCYANATE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; METAL NANOPARTICLE; RHODAMINE; RHODAMINE DEXTRAN; SILVER;

ARTICLE; CELL VIABILITY; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; MOLECULAR DYNAMICS; PARTICLE SIZE; POLARIMETRY; PRIORITY JOURNAL; THERMAL ANALYSIS; WOUND DRESSING; WOUND HEALING; X RAY DIFFRACTION; ANALOGS AND DERIVATIVES; ANIMAL; BANDAGE; CELL LINE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; HEP-G2 CELL LINE; INFRARED RADIATION; KERATINOCYTE; METABOLISM; MONONUCLEAR CELL; PIG; PRIMARY CELL CULTURE; THERMOTHERAPY; ULTRASTRUCTURE;

ANIMALS; BANDAGES; CELL LINE; CELL SURVIVAL; CHITOSAN; DEXTRANS; DRUG DELIVERY SYSTEMS; FIBROBLASTS; FLUORESCEIN-5-ISOTHIOCYANATE; HEP G2 CELLS; HUMANS; HYPERTHERMIA, INDUCED; INFRARED RAYS; KERATINOCYTES; LEUKOCYTES, MONONUCLEAR; METAL NANOPARTICLES; PARTICLE SIZE; PRIMARY CELL CULTURE; RHODAMINES; SILVER; SWINE; X-RAY DIFFRACTION;

EID: 84960440095     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2016.02.038     Document Type: Article

References (67)

1. Bernkop-Schnürch A., Dünnhaupt S. Chitosan-based drug delivery systems. Eur. J. Pharm. Biopharm. 2012, 81(3):463-469.
2. Boucard N., Viton C., Agay D., Mari E., Roger T., Chancerelle Y., Domard A. The use of physical hydrogels of chitosan for skin regeneration following third-degree burns. Biomaterials 2007, 28(24):3478-3488.
3. Dai T., Tanaka M., Huang Y.Y., Hamblin M.R. Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects. Expert Rev. of Anti-Infect. Ther. 2011, 9(7):857-879.
4. Dantas M., Cavalcante D., Araújo F., Barretto S., Aciole G., Pinheiro A., Ribeiro M., Lima-Verde I., Melo C., Cardoso J. Improvement of dermal burn healing by combining sodium alginate/chitosan-based films and low level laser therapy. J. Photochem. Photobiol. B: Biol. 2011, 105(1):51-59.
5. Jayakumar R., Prabaharan M., Kumar P.S., Nair S., Tamura H. Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnol. Adv. 2011, 29(3):322-337.
6. Qin C., Li H., Xiao Q., Liu Y., Zhu J., Du Y. Water-solubility of chitosan and its antimicrobial activity. Carbohydr. Polym. 2006, 63(3):367-374.
7. Shi C., Zhu Y., Ran X., Wang M., Su Y., Cheng T. Therapeutic potential of chitosan and its derivatives in regenerative medicine. J. Surg. Res. 2006, 133(2):185-192.
8. Zheng L.-Y., Zhu J.-F. Study on antimicrobial activity of chitosan with different molecular weights. Carbohydr. Polym. 2003, 54(4):527-530.
9. Bégin A., Van Calsteren M.-R. Antimicrobial films produced from chitosan. Int. J. Biol. Macromol. 1999, 26(1):63-67.
10. Li L.-H., Deng J.-C., Deng H.-R., Liu Z.-L., Li X.-L. Preparation, characterization and antimicrobial activities of chitosan/Ag/ZnO blend films. Chem. Eng. J. 2010, 160(1):378-382.
11. Rhim J.-W., Hong S.-I., Park H.-M., Ng P.K. Preparation and characterization of chitosan-based nanocomposite films with antimicrobial activity. J. Agric. Food Chem. 2006, 54(16):5814-5822.
12. Yan X.L., Khor E., Lim L.Y. Chitosan-alginate films prepared with chitosans of different molecular weights. J. Biomed. Mater. Res. 2001, 58(4):358-365.
13. Regiel A., Irusta S., Kyzioł A., Arruebo M., Santamaria J. Preparation and characterization of chitosan-silver nanocomposite films and their antibacterial activity against Staphylococcus aureus. Nanotechnology 2013, 24(1):015101.
14. Vimala K., Mohan Y.M., Sivudu K.S., Varaprasad K., Ravindra S., Reddy N.N., Padma Y., Sreedhar B., MohanaRaju K. Fabrication of porous chitosan films impregnated with silver nanoparticles: a facile approach for superior antibacterial application. Colloids Surf. B 2010, 76(1):248-258.
15. Lu S., Gao W., Gu Construction H.Y. application and biosafety of silver nanocrystalline chitosan wound dressing. Burns 2008, 34(5):623-628.
16. Pinto R.J., Fernandes S.C., Freire C.S., Sadocco P., Causio J., Neto C.P., Trindade T. Antibacterial activity of optically transparent nanocomposite films based on chitosan or its derivatives and silver nanoparticles. Carbohydr. Res. 2012, 348:77-83.
17. ®. Burns 2014, 40(1):89-96.
18. Dunn K., Edwards-Jones V. The role of acticoat™ with nanocrystalline silver in the management of burns. Burns 2004, 30:S1-S9.
19. Ge L., Li Q., Wang M., Ouyang J., Li X., Xing M.M.Q. Nanosilver particles in medical applications: synthesis, performance, and toxicity. Int. J. Nanomed. 2014, 9:2399-2407.
20. Pal S., Tak Y.K., Song J.M. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl. Environ. Microbiol. 2007, 73(6):1712-1720.
21. El-Zahry M.R., Mahmoud A., Refaat I.H., Mohamed H.A., Bohlmann H., Lendl B. Antibacterial effect of various shapes of silver nanoparticles monitored by SERS. Talanta 2015, 138:183-189.
22. Aherne D., Ledwith D.M., Gara M., Kelly J.M. Optical properties and growth aspects of silver nanoprisms produced by a highly reproducible and rapid synthesis at room temperature. Adv. Funct. Mater. 2008, 18(14):2005-2016.
23. Jahnen-Dechent W., Simon U. Function follows form: shape complementarity and nanoparticle toxicity. Nanomedicine 2008, 3(5):601-603.
24. Powers K.W., Palazuelos M., Moudgil B.M., Roberts S.M. Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies. Nanotoxicology 2007, 1(1):42-51.
25. Thompson E.A., Graham E., MacNeill C.M., Young M., Donati G., Wailes E.M., Jones B.T., Levi-Polyachenko N.H. Differential response of MCF7, MDA-MB-231, and MCF 10A cells to hyperthermia, silver nanoparticles and silver nanoparticle-induced photothermal therapy. Int. J. Hyperth. 2014, 30(5):312-323.
26. Gurunathan S., Lee K.-J., Kalishwaralal K., Sheikpranbabu S., Vaidyanathan R., Eom S.H. Antiangiogenic properties of silver nanoparticles. Biomaterials 2009, 30(31):6341-6350.
27. Kalishwaralal K., Banumathi E., Pandian S.R.K., Deepak V., Muniyandi J., Eom S.H., Gurunathan S. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids Surf. B 2009, 73(1):51-57.
28. Sriram M.I., Kanth S.B.M., Kalishwaralal K., Gurunathan S. Antitumor activity of silver nanoparticles in Dalton's lymphoma ascites tumor model. Int. J. Nanomed. 2010, 5:753.
29. Serda R.E., Gu J., Bhavane R.C., Liu X., Chiappini C., Decuzzi P., Ferrari M. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials 2009, 30(13):2440-2448.
30. Decuzzi P., Pasqualini R., Arap W., Ferrari M. Ferrari Intravascular delivery of particulate systems: does geometry really matter?. Pharm. Res. 2009, 26(1):235-243.
31. Wang S., Lu W., Tovmachenko O., Rai U.S., Yu H., Ray P.C. Challenge in understanding size and shape dependent toxicity of gold nanomaterials in human skin keratinocytes. Chem. Phys. Lett. 2008, 463(1):145-149.
32. Brown S.C., Kamal M., Nasreen N., Baumuratov A., Sharma P., Antony V.B., Moudgil B.M. Influence of shape, adhesion and simulated lung mechanics on amorphous silica nanoparticle toxicity. Adv. Powder Technol. 2007, 18(1):69-79.
33. Celeste C.J., Deschesne K., Riley C.B., Theoret C.L. Skin temperature during cutaneous wound healing in an equine model of cutaneous fibroproliferative disorder: kinetics and anatomic-site differences. Vet. Surg. 2013, 42(2):147-153.
34. Celeste C.J., Deschesne K., Riley C.B., Theoret C.L. Skin temperature during cutaneous wound healing in an equine model of cutaneous fibroproliferative disorder: kinetics and anatomic-site differences. Vet. Surg. 2013, 42(2):147-153.
35. Jain M., Shakya M. An infinite element model to study temperature variations during wound healing process after plastic surgery. Infin. Dimens. Anal. Qu. Probab. Relat. Top. 2011, 14(02):209-224.
36. Kruse C.R., Nuutila K., Lee C.C., Kiwanuka E., Singh M., Caterson E.J., Eriksson E., Sørensen J.A. The external microenvironment of healing skin wounds. Wound Repair Regen. 2015.
37. McGuiness W., Vella E., Harrison D. Influence of dressing changes on wound temperature. J. Wound Care 2004, 13(9):383-385.
38. Kloth L.C., Berman J.E., Nett M., Papanek P.E., Dumit-Minkel S. A randomized controlled clinical trial to evaluate the effects of noncontact normothermic wound therapy on chronic full-thickness pressure ulcers. Adv. Skin Wound Care 2002, 15(6):270-276.
39. Whitney J.D., Salvadalena G., Higa L., Mich M. Treatment of pressure ulcers with noncontact normothermic wound therapy: healing and warming effects. J. Wound Ostomy Continence Nurs. 2001, 28(5):244-252.
40. Whitney J.D., Wickline M.M. Treating chronic and acute wounds with warming: review of the science and practice implications. J. Wound Ostomy Continence Nur. 2003, 30(4):199-209.
41. Homan K.A., Souza M., Truby R., Luke G.P., Green C., Vreeland E., Emelianov S. Silver nanoplate contrast agents for in vivo molecular photoacoustic imaging. ACS Nano 2012, 6(1):641-650.
42. Lee K.-S., El-Sayed M.A. Gold and silver nanoparticles in sensing and imaging: sensitivity of plasmon response to size, shape, and metal composition. J. Phys. Chem. B 2006, 110(39):19220-19225.
43. Mock J., Barbic M., Smith D., Schultz D., Schultz S. Shape effects in plasmon resonance of individual colloidal silver nanoparticles. J. Chem. Phys. 2002, 116(15):6755-6759.
44. Boca S.C., Potara M., Gabudean A.-M., Juhem A., Baldeck P.L., Astilean S. Chitosan-coated triangular silver nanoparticles as a novel class of biocompatible, highly effective photothermal transducers for in vitro cancer cell therapy. Cancer Lett. 2011, 311(2):131-140.
45. Gupta A.K., Curtis A.S. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture. J. Mater. Sci. 2004, 15(4):493-496.
46. Meyer D.E., Kong G.A., Dewhirst M.W., Zalutsky M.R., Chilkoti A. Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. Cancer Res. 2001, 61(4):1548-1554.
47. Upadhyay P. Enhanced transdermal-immunization with diptheria-toxoid using local hyperthermia. Vaccine. 2006, 24(27):5593-5598.
48. Kilmer S.L., Anderson R. Clinical use of the Q-Switched ruby and the Q-Nd: yAG (1064 nm and 532 nm) lasers for treatment of tattoos. J. Dermatol. Surg. Oncol. 1993, 19(4):330-338.
49. Ibrahimi O.A., Avram M.M., Hanke C.W., Kilmer S.L., Anderson R. Laser hair removal. Dermatol. Ther. 2011, 24(1):94-107.
50. Nanni C.A., Alster T.S. Laser-assisted hair removal: side effects of Q-switched Nd: YAG, long-pulsed ruby, and alexandrite lasers. J. Am. Acad. Dermatol. 1999, 41(2):165-171.
51. Kent K.M., Graber E.M. Laser tattoo removal: a review. Dermatol. Surg. 2012, 38(1):1-13.
52. Austin L.A., Mackey M.A., Dreaden E.C., El-Sayed M.A. The optical, photothermal, and facile surface chemical properties of gold and silver nanoparticles in biodiagnostics, therapy, and drug delivery. Arch. Toxicol. 2014, 88(7):1391-1417.
53. Fribourg-Blanc E., Dang D.T.M., Le T.T.T., Trinh C.D., Thanh T.T.N., Dang C.M. Investigation of shape controlled silver nanoplates by a simple chemical reduction method. Nano 2013, 8(03):1350030.
54. Bin Ahmad M., Lim J.J., Shameli K., Ibrahim N.A., Tay M.Y. Synthesis of silver nanoparticles in chitosan, gelatin and chitosan/gelatin bionanocomposites by a chemical reducing agent and their characterization. Molecules 2011, 16(9):7237-7248.
55. Qi L., Xu Z., Jiang X., Hu C., Zou X. Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr. Res. 2004, 339(16):2693-2700.
56. Aguzzi C., Sandri G., Bonferoni C., Cerezo P., Rossi S., Ferrari F., Caramella C., Viseras C. Solid state characterisation of silver sulfadiazine loaded on montmorillonite/chitosan nanocomposite for wound healing. Colloids Surf. B: Biointerfaces 2014, 113:152-157.
57. Sun Y., Xia Y. Shape-controlled synthesis of gold and silver nanoparticles. Science 2002, 298(5601):2176-2179.
58. Rumengan I., Suryanto E., Modaso R., Wullur S., Tallei T., Limbong D. Structural characteristics of chitin abd chitosan isolated from the biomass of cultivated rotifer, brachionus rotundiformis. Int. J. Fish. Aquat. Sci. 2014, 3(1):12-18.
59. Ali S.W., Rajendran S., Joshi M. Synthesis and characterization of chitosan and silver loaded chitosan nanoparticles for bioactive polyester. Carbohydr. Polym. 2011, 83(2):438-446.
60. Kolhe P., Kannan R.M. Improvement in ductility of chitosan through blending and copolymerization with PEG: FTIR investigation of molecular interactions. Biomacromolecules 2003, 4(1):173-180.
61. Cardenas G., Miranda S.P. FTIR and TGA studies of chitosan composite films. J. Chil. Chem. Soc. 2004, 49(4):291-295.
62. González-Campos J.B., Prokhorov E., Luna-Bárcenas G., Sanchez I.C., Lara-Romero J., Mendoza-Duarte M., Villaseñor F., Guevara-Olvera L. Chitosan/silver nanoparticles composite: molecular relaxations investigation by dynamic mechanical analysis and impedance spectroscopy. J. Polym. Sci. B: Polym. Phys. 2010, 48(7):739-748.
63. Nunthanid J., Puttipipatkhachorn S., Yamamoto K., Peck G.E. Physical properties and molecular behavior of chitosan films. Drug Dev. Ind. Pharm. 2001, 27(2):143-157.
64. Kawata K., Osawa M., Okabe S. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ. Sci. Technol. 2009, 43(15):6046-6051.
65. Arora S., Jain J., Rajwade J., Paknikar K. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol. Appl. Pharmacol. 2009, 236(3):310-318.
66. Liu X., y.Lee P., m.Ho C., Lui V.C., Chen Y., m.Che C., Tam P.K., Wong K.K. Silver nanoparticles mediate differential responses in keratinocytes and fibroblasts during skin wound healing. ChemMedChem 2010, 5(3):468-475.
67. Riva R., Ragelle H., des Rieux A., Duhem N., Jérôme C., Préat V. Chitosan and chitosan derivatives in drug delivery and tissue engineering. Chitosan for biomaterials II 2011, 19-44. Springer.